Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Cancer Drug Development with the Help of Radiopharmaceuticals: Academic Experience

Author(s): Steven M. Larson

Volume 15, Issue 9, 2009

Page: [950 - 956] Pages: 7

DOI: 10.2174/138161209787581959

Price: $65

Abstract

In the last decade radiotracers have been gradually growing in importance as aids for the development of new drugs. This development has been most pronounced for Psychiatric and Neurologic drugs [1, 2], but has more recently been adapted to the development of drugs against cancer. In this mini-review, we describe how advances in molecular imaging of cancer are likely to lead to advances in development and improved application of anti-cancer drugs [3]. We will focus on 4 aspects of use of radiotracers: 1) for treatment response assessment; 2) for the study of kinetics and pharmacology of novel drugs, including bioavailability and local tumor concentration; 3) the identification of the biologic target at the cellular level; 4) the combination of nanocarriers and radioisotopes to improve biodistribution.

Keywords: Drug Development, radiotracers, molecular imaging, anti-cancer drugs, Cancer Biology


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy